Status of
COVID-19 vaccines
and therapies

COVID-19 vaccines and therapies have
dominated recent development activity.

Download the report

Vaccine/Therapy Name Type Countries Manufacturer
Ad5-nCoV (Convidecia™) Single-dose recombinant viral vector vaccine Beijing Institute of Biotechnology of the Academy of Military Medical Sciences, CanSino Biologics Inc.
AZD-1222 Two-dose recombinant viral vector vaccine AstraZeneca plc, University of Oxford
Bamlanivimab (LY-3819253, LY-CoV555) MAb Abcellera Biologics Inc., Eli Lilly and Co.
Baricitinib (OLUMIANT®) Janus kinase inhibitor Eli Lilly and Co., Incyte Corp.
BBIBP-CorV Two-dose inactivated vaccine Beijing Institute of Biological Products Co. Ltd, Henan Provincial Center for Disease Control and Prevention
Casirivimab and imdevimab MAb Regeneron Pharmaceuticals Inc., Roche
CoronaVac Two-dose inactivated vaccine Bio Farma, Dynavax Technologies, Instituto Butantan, Sinovac Biotech Ltd.
COVAXIN® Two-dose inactivated vaccine Bharat Biotech International, Ocugen Inc.
CoviVac Two-dose inactivated vaccine Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Science
Dexamethasone phosphate (DEXAVAN) Corticosteroid Bausch Health, Oxford University
EpiVacCorona Two-dose synthetic peptide State Research Center of Virology and Biotechnology VECTOR
Etesevimab (LY-CoV016) MAb Abcellera Biologics Inc., Eli Lilly and Co., Shanghai Junshi Biosciences Co. Ltd.
Favipiravir (Reeqonus™, Avigan®) Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor Appili Therapeutics, Dr. Reddy's Laboratories Ltd., Fujifilm Holdings, Fujifilm Toyama Chemical Co. Ltd., Genentech, Glenmark Pharmaceuticals Ltd., Medivector Inc., Sihuan Pharmaceutical Holdings Group, Zhejiang Hisun Pharmaceutical Co. Ltd.
Gam-COVID-Vac (Sputnik V) Two-dose recombinant viral vector vaccine Gamaleya Research Institute of Epidemiology and Microbiology
JNJ-78436735 (Ad26.COV2-S) Single-dose recombinant viral vector vaccine Biomedical Advanced Research and Development Authority (BARDA), Catalent, Emergent Biosolutions®, Grand River Aseptic Manufacturing, Johnson & Johnson
mRNA-1273 (TAK-919; elasomeran; SPIKEVAC™) Two-dose, lipid nanoparticle RNA vaccine Catalent, Ginkgo Bioworks, Moderna Therapeutics, Recipharm, Takeda Pharmaceutical Co. Ltd.
Nirmatrelvir and ritonavir (PF-07321332; PAXLOVID™) Main protease (Mpro) inhibitor Pfizer Inc.
Regdanvimab (Regkirona; CT-P59) MAb Celltrion
Remdesivir (VEKLURY®) Broad-spectrum antiviral; Viral RNA-dependent, RNA polymerase inhibitor Cipla Limited, Dr. Reddy's Laboratories Ltd., Gilead Sciences Inc., Hetero
Sotrovimab (GSK4182136, VIR-7831, VIR-7832) MAb Biogen Inc., GlaxoSmithKline plc, National Institute of Allergy and Infectious Diseases (NIAID), Samsung Biologics, Vir Biotechnology, Wuxi Biologics, Xencor Inc.
Tixagevimab and cilgavimab (AZD-7442; combination of AZD-8895 and AZD-1061; Evusheld) MAb AstraZeneca plc
Tocilizumab (Actemra; Roactemra) MAb Chugai, Genentech
Tozinameran (BNT-162b2, COMIRNATY®) Two-dose, lipid nanoparticle RNA vaccine BioNTech SE, Fosun Pharma, Pfizer Inc.
ZF2001 (RBD-dimer, Zifivax) Three-dose protein subunit Anhui Zhifei Longcom Biopharmaceutical Co. Ltd., Chinese Academy of Sciences
ZyCov-D Three-dose DNA Zydus Cadila Healthcare Ltd.

Resources

Truly differentiate your drug

Access our global intelligence, advanced analytics and global team of experts.

Speak to our team